Lumen
PrivateLast Round
Series C
Extension
Oct 8, 2025
Total Funding Raised
$100.55M
Momentum Score
25 /100
Company Overview
Lumen Bioscience is a biosciences company focused on accelerating the development of biologic drugs through innovative technology that enhances speed, scalability, and cost-effectiveness, addressing global diseases with limited treatment options.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Clean Manufacturing
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumen Comps
Public and private peers based on sector, stage, and business model.
Lumen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Oct 8, 2025 | ||||
| Grant | Oct 17, 2023 | ||||
| VC Round | Jun 1, 2022 | ||||
| Grant | Jan 27, 2021 | ||||
| Series B | Sep 1, 2020 | ||||
Series A | Dec 5, 2017 |
Key People
Founding team and executive leadership
Lumen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| U.S. Department of Defense | Grant |
| Gates Family Foundation | Series C Extension |
| Gates Foundation | Series C Extension |
| WestRiver Group | Series C Extension, Series B |
| The Bill & Melinda Gates Foundation Trust | Grant, Series C Extension |
| Bioeconomy Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
Achieved FSCC 22000 food safety certification.
- Oct 8, 2025
Jeff Raikes, former Microsoft president, joins the board.
Lumen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lumen's valuation, stock price, and market status.
